Insider · CIK 0001851636
Pierre A. Morgon
Files at BRNS (Barinthus Biotherapeutics plc.). First filing -, latest -.
Pierre A. Morgon files SEC Form 4 as director at BRNS (Barinthus Biotherapeutics plc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Pierre A. Morgon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Ordinary Shares | -10,506 | - | - | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -20,394 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -34,328 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -18,604 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -19,197 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -19,516 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -20,174 | $0.00 | $0 | 0 | 34 d ago |
| Jun 10, 2025 | BRNS Barinthus Biotherapeutics plc. | AGrant or award Share Option (Right to Buy)derivative | +20,174 | $0.00 | $0 | 20,174 | Jun 11, 2025 |
Questions about Pierre A. Morgon
Answered from the filings on this page, as of the latest one.
Is Pierre A. Morgon buying or selling?
Pierre A. Morgon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Pierre A. Morgon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pierre A. Morgon has 0.
Where does Pierre A. Morgon file Form 4?
Pierre A. Morgon has filed Form 4 at BRNS (Barinthus Biotherapeutics plc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.